<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Case Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am J Case Rep</journal-id>
      <journal-id journal-id-type="publisher-id">amjcaserep</journal-id>
      <journal-title-group>
        <journal-title>The American Journal of Case Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1941-5923</issn>
      <publisher>
        <publisher-name>International Scientific Literature, Inc.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26237079</article-id>
      <article-id pub-id-type="pmc">4527206</article-id>
      <article-id pub-id-type="doi">10.12659/AJCR.893803</article-id>
      <article-id pub-id-type="publisher-id">893803</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pancreatic Gastrointestinal Stromal Tumor after Upper Gastrointestinal Hemorrhage and Performance of Whipple Procedure: A Case Report and Literature Review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Aziret</surname>
            <given-names>Mehmet</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn1-amjcaserep-16-509">
            <sup>A</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn2-amjcaserep-16-509">
            <sup>B</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-16-509">
            <sup>E</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn6-amjcaserep-16-509">
            <sup>F</sup>
          </xref>
          <xref ref-type="aff" rid="af1-amjcaserep-16-509">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="c1-amjcaserep-16-509"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#xC7;etink&#xFC;nar</surname>
            <given-names>S&#xFC;leyman</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn1-amjcaserep-16-509">
            <sup>A</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn2-amjcaserep-16-509">
            <sup>B</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-16-509">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Akta&#x15F;</surname>
            <given-names>Elife</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn2-amjcaserep-16-509">
            <sup>B</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn3-amjcaserep-16-509">
            <sup>C</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn4-amjcaserep-16-509">
            <sup>D</sup>
          </xref>
          <xref ref-type="aff" rid="af3-amjcaserep-16-509">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#x130;rk&#xF6;r&#xFC;c&#xFC;</surname>
            <given-names>Oktay</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn2-amjcaserep-16-509">
            <sup>B</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn5-amjcaserep-16-509">
            <sup>E</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn6-amjcaserep-16-509">
            <sup>F</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-16-509">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bali</surname>
            <given-names>&#x130;lhan</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn4-amjcaserep-16-509">
            <sup>D</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn6-amjcaserep-16-509">
            <sup>F</sup>
          </xref>
          <xref ref-type="aff" rid="af4-amjcaserep-16-509">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Erdem</surname>
            <given-names>Hasan</given-names>
          </name>
          <xref ref-type="author-notes" rid="fn3-amjcaserep-16-509">
            <sup>C</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn4-amjcaserep-16-509">
            <sup>D</sup>
          </xref>
          <xref ref-type="aff" rid="af2-amjcaserep-16-509">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="af1-amjcaserep-16-509"><label>1</label>Department of General Surgery, Kars State Hospital, Kars, Turkey</aff>
      <aff id="af2-amjcaserep-16-509"><label>2</label>Department of General Surgery, Adana Numune Training and Research Hospital, Adana, Turkey</aff>
      <aff id="af3-amjcaserep-16-509"><label>3</label>Department of Pathology, Adana Numune Training and Research Hospital, Adana, Turkey</aff>
      <aff id="af4-amjcaserep-16-509"><label>4</label>Department of General Surgery, Nam&#x131;k Kemal University, Tekirda&#x131;, Turkey</aff>
      <author-notes>
        <fn>
          <p>Authors&#x2019; Contribution:</p>
        </fn>
        <fn id="fn1-amjcaserep-16-509">
          <label>A</label>
          <p>Study Design</p>
        </fn>
        <fn id="fn2-amjcaserep-16-509">
          <label>B</label>
          <p>Data Collection</p>
        </fn>
        <fn id="fn3-amjcaserep-16-509">
          <label>C</label>
          <p>Statistical Analysis</p>
        </fn>
        <fn id="fn4-amjcaserep-16-509">
          <label>D</label>
          <p>Data Interpretation</p>
        </fn>
        <fn id="fn5-amjcaserep-16-509">
          <label>E</label>
          <p>Manuscript Preparation</p>
        </fn>
        <fn id="fn6-amjcaserep-16-509">
          <label>F</label>
          <p>Literature Search</p>
        </fn>
        <fn id="fn7-amjcaserep-16-509">
          <label>G</label>
          <p>Funds Collection</p>
        </fn>
        <fn id="fn8-amjcaserep-16-509" fn-type="presented-at">
          <p>This study was a feature presentation at the 19<sup>th</sup> National Surgical Congress in Turkey</p>
        </fn>
        <fn id="fn9-amjcaserep-16-509">
          <p><bold>Conflict of interest:</bold> None declared</p>
        </fn>
        <corresp id="c1-amjcaserep-16-509">Corresponding Author: Mehmet Aziret, e-mail: <email>mhmtaziret@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <fpage>509</fpage>
      <lpage>513</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Am J Case Rep, 2015</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license>
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</license-p>
        </license>
      </permissions>
      <abstract>
        <p>
          <bold>Patient: Male, 56</bold>
        </p>
        <p>
          <bold>Final Diagnosis: Pancreatic GIST</bold>
        </p>
        <p>
          <bold>Symptoms: Abdominal pain</bold>
        </p>
        <p>
          <bold>Medication: None</bold>
        </p>
        <p>
          <bold>Clinical Procedure: Whipple procedure</bold>
        </p>
        <p>
          <bold>Specialty: Surgery</bold>
        </p>
        <sec>
          <title>Objective:</title>
          <p>
            <bold>Rare disease</bold>
          </p>
        </sec>
        <sec>
          <title>Background:</title>
          <p>Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the gastrointestinal system. These types of tumors originate from any part of the tract as well as from the intestine, colon, omentum, mesentery or retroperitoneum. GIST is a rare tumor compared to other types of tumors, accounting for less than 1% of all gastrointestinal tumors.</p>
        </sec>
        <sec>
          <title>Case Report:</title>
          <p>A 56-year-old male patient was hospitalized due to an upper gastrointestinal hemorrhage and the start of abdominal pain on the same day. In the upper gastrointestinal endoscopy that was performed, a solitary mass was found in the second section of the duodenum and a blood vessel (Forrest type 2a) was seen. The extent and location of the mass was detected by abdominal tomography. After hemodynamic recovery, a Whipple procedure was performed without any complications. A subsequent histopathological examination detected a c-kit-positive (CD117) pancreatic GIST with high mitotic index.</p>
        </sec>
        <sec>
          <title>Conclusions:</title>
          <p>The most effective treatment method for GISTs is surgical resection. In patients with a head of pancreatic GIST, the Whipple procedure can be used more safely and effectively.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>MeSH Keywords</title>
        <kwd>Gastrointestinal Stromal Tumors</kwd>
        <kwd>Pancreaticoduodenectomy</kwd>
        <kwd>Receptor Protein-Tyrosine Kinases</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>GIST is a rare mesenchymal tumor in the gastrointestinal tract [<xref rid="b1-amjcaserep-16-509" ref-type="bibr">1</xref>]. In Switzerland and Iceland, the annual incidence rates are 14.5/1 000 000 and 3/1 000 000, respectively, and in the USA, there are about 4000 new cases every year [<xref rid="b2-amjcaserep-16-509" ref-type="bibr">2</xref>&#x2013;<xref rid="b4-amjcaserep-16-509" ref-type="bibr">4</xref>]. Extra-gastrointestinal stromal tumors (EGISTs) originate from outside of the gastrointestinal tract and are usually seen in the omentum, mesentery, retroperitoneal, or other intra-abdominal localizations [<xref rid="b3-amjcaserep-16-509" ref-type="bibr">3</xref>,<xref rid="b4-amjcaserep-16-509" ref-type="bibr">4</xref>]. The incidence rate of EGIST is 7&#x2013;10/1 000 000 [<xref rid="b2-amjcaserep-16-509" ref-type="bibr">2</xref>,<xref rid="b7-amjcaserep-16-509" ref-type="bibr">7</xref>]. Pancreatic GISTs, with an annual incidence rate of 3/1 000 000, are part of the same family as EGISTs but have been less reported on in the literature [<xref rid="b3-amjcaserep-16-509" ref-type="bibr">3</xref>,<xref rid="b5-amjcaserep-16-509" ref-type="bibr">5</xref>]. While the etiopathogenesis of EGISTs is not clearly defined, it is believed to arise from the progenitor of Cajal cells, which are responsible for providing communication between the muscular layer and myenteric layers after mutations of the tyrosine kinase receptors, such as c-kit and platelet-derived growth factor receptor oncogene alpha (PDGFRA) [<xref rid="b6-amjcaserep-16-509" ref-type="bibr">6</xref>,<xref rid="b7-amjcaserep-16-509" ref-type="bibr">7</xref>]. In patients with EGISTs, medical and surgical adjuvant therapy with tyrosine kinase inhibitors, such as imatinib (imatinib mesylate, Glivec&#x2122;, STI-571) has been shown to reduce the risk of recurrence and increase survival after 1 year of therapy [<xref rid="b7-amjcaserep-16-509" ref-type="bibr">7</xref>,<xref rid="b9-amjcaserep-16-509" ref-type="bibr">9</xref>].</p>
      <p>The following report presents a case of pancreatic GIST that received follow-up care and treatment after upper gastrointestinal hemorrhage and the performance of a Whipple procedure at our clinic.</p>
    </sec>
    <sec>
      <title>Case Report</title>
      <p>A 56-year-old male patient was hospitalized due to an upper gastrointestinal hemorrhage and abdominal pain. The patient&#x2019;s history revealed that the hemorrhage had started on the same day as one of his episodes of abdominal pain, which had been ongoing for 3 months. His body mass index (BMI) was 20 kg/m<sup>2</sup>, and over a period of 6 months he had lost 10 kg body weight. The patient&#x2019;s hemoglobin and hematocrit levels were 7.2 mg/dl and 22.8%, respectively. He was taken to the intensive care unit, where he was monitored and administered oxygen and intravenous fluids. The patient was then given 2 units of erythrocyte suspension and 1 unit of fresh frozen plasma, and an upper endoscopy was planned. In the upper gastrointestinal endoscopy that was performed, a solid mass was detected in the second section of the duodenum and a blood vessel (Forrest type 2a) was seen. Hemostasis was performed using hemoclips and the injection of adrenaline. A solitary mass, 4 cm in diameter, was observed in the second section of the duodenum in the abdominal ultrasonography (USG) and contrast-enhanced computed tomography (CT) (<xref ref-type="fig" rid="f1-amjcaserep-16-509">Figures 1</xref>, <xref ref-type="fig" rid="f2-amjcaserep-16-509">2</xref>). A control upper GIS endoscopy was conducted and numerous biopsies were taken from the mass. However, the results of the biopsies were inadequate. Following an anesthesia consultation, it was determined that his physical status was ASA-3 (American Society of Anesthesiologists). The patient&#x2019;s tumor markers were normal and an abdominal operation was planned. A midline laparotomy was performed and after opening the abdominal cavity and conducting an exploration, a tumoral mass, approximately 4 cm in diameter and consisting of the head of the pancreas and uncinate process, was found. After no invasion of adjacent tissue or metastases was seen, a Whipple procedure (pancreaticoduodenectomy) was performed without any complications (<xref ref-type="fig" rid="f3-amjcaserep-16-509">Figure 3</xref>). A subsequent histopathological examination showed a c-kit-positive (CD117) GIST with a high mitotic index and pancreas origin. The tumor was not seen in the surgical margins (<xref ref-type="fig" rid="f3-amjcaserep-16-509">Figures 3</xref><xref ref-type="fig" rid="f4-amjcaserep-16-509"/><xref ref-type="fig" rid="f5-amjcaserep-16-509"/><xref ref-type="fig" rid="f6-amjcaserep-16-509"/>&#x2013;<xref ref-type="fig" rid="f7-amjcaserep-16-509">7</xref>). The patient was discharged in good condition on the sixteenth day following the procedure. His general condition continues to be good and he receives regular follow-up care at the Oncology Department, where he is administered imatinib treatment.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>GISTs are the most common mesenchymal tumors of the gastrointestinal tract malignities [<xref rid="b1-amjcaserep-16-509" ref-type="bibr">1</xref>,<xref rid="b2-amjcaserep-16-509" ref-type="bibr">2</xref>]. The tumors were originally defined by Golden and Stout in 1941 as <italic>bona fide</italic> smooth muscle tumors or precursors of leiomyoma [<xref rid="b3-amjcaserep-16-509" ref-type="bibr">3</xref>]. After the discovery of electron microscopy and immunohistochemical (IHC) analysis, Mazur and Clark were the first to use the term &#x201C;stromal tumor&#x201D; in 1983 [<xref rid="b4-amjcaserep-16-509" ref-type="bibr">4</xref>].</p>
      <p>GISTs represent less than 1% of all gastrointestinal tumors [<xref rid="b5-amjcaserep-16-509" ref-type="bibr">5</xref>]. The most common locations of these tumors are the stomach (50&#x2013;70%), small bowel (20&#x2013;30%) and colon/rectum (10%) [<xref rid="b5-amjcaserep-16-509" ref-type="bibr">5</xref>]. EGISTs are frequently located in the omentum, mesentery or retroperitoneum. Cases of pancreatic GIST are extremely rare [<xref rid="b5-amjcaserep-16-509" ref-type="bibr">5</xref>,<xref rid="b6-amjcaserep-16-509" ref-type="bibr">6</xref>]. Agaimi et al. [<xref rid="b6-amjcaserep-16-509" ref-type="bibr">6</xref>] reported a 1.5% rate of EGISTs in all of GISTs. These tumors are most often seen in the middle to later stages of life, where the 60&#x2013;80 year old age group constitute the highest proportion of cases and 75% of cases are over 50 years old (median age: 58) [<xref rid="b3-amjcaserep-16-509" ref-type="bibr">3</xref>,<xref rid="b4-amjcaserep-16-509" ref-type="bibr">4</xref>,<xref rid="b6-amjcaserep-16-509" ref-type="bibr">6</xref>]. The etiopathogenesis of GISTs has not been definitively described. Based on the immunophenotypic characterization and the similarity of ultrastructural and cell signaling in GIST pathogenesis, it is believed that the c-kit positive cells of the ICC (Interstitial Cells of Cajal) progenitor are generated by somatic mutations of PDFR&#x3B1; or KIT (CD117, c-kit) [<xref rid="b7-amjcaserep-16-509" ref-type="bibr">7</xref>]. Most GIST cases are isolated incidences; however, in families with c-KIT and platelet-derived growth factor-&#x3B1; (PDGFR-&#x3B1;) mutations and neurofibromatosis Type 1, the incidence of EGIST increases [<xref rid="b7-amjcaserep-16-509" ref-type="bibr">7</xref>]. In immunohistochemical studies, CD117-positive cells have been found in the omentum and mesothelial [<xref rid="b8-amjcaserep-16-509" ref-type="bibr">8</xref>]. The immunohistochemical staining done in our case showed that tumor cells were stained with CD117 (c-KIT), CD34 and actin (<xref ref-type="fig" rid="f4-amjcaserep-16-509">Figures 4</xref><xref ref-type="fig" rid="f5-amjcaserep-16-509"/>&#x2013;<xref ref-type="fig" rid="f6-amjcaserep-16-509">6</xref>).</p>
      <p>GISTs include a wide array of symptoms, which may vary according to location in the GI tract, tumor size and localization of the organ wall. Patients may even be asymptomatic, depending on tumor size and location [<xref rid="b3-amjcaserep-16-509" ref-type="bibr">3</xref>,<xref rid="b7-amjcaserep-16-509" ref-type="bibr">7</xref>]. Benign tumors are usually asymptomatic due to their small size and are typically discovered incidentally during the performance of surgery for another reason. However, some benign tumors can cause symptoms such as gastrointestinal bleeding and abdominal pain [<xref rid="b7-amjcaserep-16-509" ref-type="bibr">7</xref>,<xref rid="b8-amjcaserep-16-509" ref-type="bibr">8</xref>]. In addition to abdominal pain, symptomatic patients may also experience hemorrhaging, loss of appetite, weight loss, weakness and fatigue, dysphagia and other complications, such as ileus and perforation [<xref rid="b1-amjcaserep-16-509" ref-type="bibr">1</xref>,<xref rid="b4-amjcaserep-16-509" ref-type="bibr">4</xref>,<xref rid="b5-amjcaserep-16-509" ref-type="bibr">5</xref>,<xref rid="b8-amjcaserep-16-509" ref-type="bibr">8</xref>]. A study of 288 primary GIST patients conducted by Nilsson et al. found that 69% of the tumors were symptomatic, 21% of the cases were found incidentally during surgery and the remaining 10% of the cases were discovered during performance of an autopsy [<xref rid="b9-amjcaserep-16-509" ref-type="bibr">9</xref>]. In our case, the patient had upper gastrointestinal bleeding and abdominal pain.</p>
      <p>The history of the patient and their symptoms, physical examinations, endoscopic interventions and imaging techniques are important in the diagnosis of EGISTs. Although endoscopy interventions are useful in cases associated with gastrointestinal lumen, GIST is difficult to diagnose in endoscopic biopsies and is often misdiagnosed as mesenchymal tumors [<xref rid="b5-amjcaserep-16-509" ref-type="bibr">5</xref>,<xref rid="b10-amjcaserep-16-509" ref-type="bibr">10</xref>]. When a deep mucosal biopsy is taken on a neoplasm, the mucosal infiltration may be given specific histological diagnosis. In our case, an upper GI endoscopy showed a solid tumoral mass in the second section of the duodenum and a blood vessel (Forrest type 2a) was seen. An endoscopic ultrasonography can be used to determine how widely the disease has spread in patients without mucosa, and an endoscopic ultrasonography with fine-needle aspiration biopsy (FNA) can be useful for diagnosis. The sensitivity of an endoscopic ultrasound in the diagnosis of malignant GIST varies between 80&#x2013;100% [<xref rid="b10-amjcaserep-16-509" ref-type="bibr">10</xref>]. Additionally, positron emission tomography (PET), computed tomography and magnetic resonance imaging (MRI) are useful for determining the extent of disease and the metabolic activity of the tumor [<xref rid="b3-amjcaserep-16-509" ref-type="bibr">3</xref>,<xref rid="b5-amjcaserep-16-509" ref-type="bibr">5</xref>,<xref rid="b7-amjcaserep-16-509" ref-type="bibr">7</xref>,<xref rid="b10-amjcaserep-16-509" ref-type="bibr">10</xref>) (<xref ref-type="fig" rid="f2-amjcaserep-16-509">Figure 2</xref>).</p>
      <p>The prognoses of GISTs vary widely according to tumor size, mitotic index, organs from which the tumor originates, and c-KIT mutation. Fletcher et al. [<xref rid="b11-amjcaserep-16-509" ref-type="bibr">11</xref>] showed that tumors have a stronger chance of being malignant in cases where they are more than 5 cm in size or in tumors that are less than 5 cm but have a number of mitosis on the 5 mitosis /50 (&gt;5&#x2013;10 mitoses per 50 high power fields) [<xref rid="b12-amjcaserep-16-509" ref-type="bibr">12</xref>]. A study of 48 cases conducted by Reith et al. [<xref rid="b2-amjcaserep-16-509" ref-type="bibr">2</xref>] reported that EGIST might show aggressive prognosis and metastases. The Armed Forces Institute of Pathology and the National Institutes of Health (NIH) published a consensus based on tumor location and morphological characteristics, which can be referenced for diagnosis and prognosis purposes [<xref rid="b8-amjcaserep-16-509" ref-type="bibr">8</xref>,<xref rid="b11-amjcaserep-16-509" ref-type="bibr">11</xref>,<xref rid="b12-amjcaserep-16-509" ref-type="bibr">12</xref>].</p>
      <p>Surgical resection is the primary treatment used to address EGISTs [<xref rid="b5-amjcaserep-16-509" ref-type="bibr">5</xref>,<xref rid="b13-amjcaserep-16-509" ref-type="bibr">13</xref>]. However, the surgical resection of a pancreatic GIST can lead to various major complications, including massive hemorrhaging and pancreatic fistulas, due to the network of main vascular vessels and major organs. In cases where the GIST resection specimens have negative surgical margins, the prognosis of the disease is positive [<xref rid="b13-amjcaserep-16-509" ref-type="bibr">13</xref>,<xref rid="b14-amjcaserep-16-509" ref-type="bibr">14</xref>]. EGISTs tend to not involve the lymphatic system; therefore, systemic lymphatic dissection may not be included in standard surgical resection [<xref rid="b14-amjcaserep-16-509" ref-type="bibr">14</xref>]. Depending on their location, gastrectomy, segmental bowel resection, hemicolectomy, pancreaticoduodenectomy (Whipple procedure), and simple excision with negative margins may be performed [<xref rid="b13-amjcaserep-16-509" ref-type="bibr">13</xref>&#x2013;<xref rid="b15-amjcaserep-16-509" ref-type="bibr">15</xref>]. Although the Whipple procedure has high morbidity and mortality, it can be used as a curative treatment option [<xref rid="b15-amjcaserep-16-509" ref-type="bibr">15</xref>]. In our case, we planned to perform a curative surgery using the Whipple procedure (<xref ref-type="fig" rid="f3-amjcaserep-16-509">Figure 3</xref>).</p>
      <p>Incomplete resection of the primary tumor is clearly associated with a much higher risk of recurrence. &#x10C;e&#x10D;ka and Dematteo reported in their studies that neo/adjuvant chemotherapy could lead to reduced rates of local recurrence in high-grade EGISTs [<xref rid="b16-amjcaserep-16-509" ref-type="bibr">16</xref>,<xref rid="b17-amjcaserep-16-509" ref-type="bibr">17</xref>]. Imatinib is a tyrosine-kinase inhibitor used in the treatment of multiple cancers, most notably GISTs and Philadelphia chromosome-positive (Ph<sup>+</sup>) chronic myelogenous leukemia (CML) [<xref rid="b9-amjcaserep-16-509" ref-type="bibr">9</xref>,<xref rid="b18-amjcaserep-16-509" ref-type="bibr">18</xref>]. Imatinib can be safely used for treatment of recurrent or metastatic GIST after surgery or unresectable tumors [<xref rid="b19-amjcaserep-16-509" ref-type="bibr">19</xref>]. The effectiveness of imatinib and the control process of the disease may be correlated with the type of mutation or the localization of KIT mutations [<xref rid="b20-amjcaserep-16-509" ref-type="bibr">20</xref>]. In tumors with exon 11 mutations, 80% of them respond well to imatinib treatment and tumors with point mutations in exon 14 also respond to imatinib treatment [<xref rid="b21-amjcaserep-16-509" ref-type="bibr">21</xref>]. However, only 50% of tumors with exon 9 respond to imatinib treatment and only partial responses have been seen in 20% of the mutation-free tumors [<xref rid="b22-amjcaserep-16-509" ref-type="bibr">22</xref>]. In our patient, imatinib treatment was planned to be administered by the Oncology Department.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>Pancreatic EGISTs are rare tumors that may be aggressive. The curative treatment method used for these tumors is surgical resection. The Whipple procedure can be safely performed in the curative surgical treatment of pancreatic GIST despite high mortality and morbidity.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Conflicts of interest</bold>
        </p>
        <p>In our study, no financial support or sponsorship was received from any person or organization.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References:</title>
      <ref id="b1-amjcaserep-16-509">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miettinen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lasota</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics</article-title>
          <source>Pol J Pathol</source>
          <year>2003</year>
          <volume>54</volume>
          <issue>1</issue>
          <fpage>3</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">12817876</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-amjcaserep-16-509">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reith</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Goldblum</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Lyles</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Extragastrointestinal (soft tissue) stromal tumours: an analysis of 48 cases with emphasis on histologic predictors of outcome</article-title>
          <source>Modern Pathology</source>
          <year>2000</year>
          <volume>13</volume>
          <fpage>577</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">10824931</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-amjcaserep-16-509">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubin</surname>
              <given-names>BP</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal stromal tumours: an update [review]</article-title>
          <source>Histopathology</source>
          <year>2006</year>
          <volume>48</volume>
          <issue>1</issue>
          <fpage>83</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">16359540</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-amjcaserep-16-509">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenson</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal stromal tumors and other mesenchymal lesions of the gut</article-title>
          <source>Mod Pathol</source>
          <year>2003</year>
          <volume>16</volume>
          <issue>4</issue>
          <fpage>366</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">12692202</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-amjcaserep-16-509">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roggin</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Posner</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Modern treatment of gastric gastrointestinal stromal tumors</article-title>
          <source>World J Gastroenterol</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>6720</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="pmid">23239909</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-amjcaserep-16-509">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agaimy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pelz</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Wieacker</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gastrointestinal stromal tumors of the vermiform appendix: clinicopathologic, immunohistochemical, and molecular study of 2 cases with literature review</article-title>
          <source>Hum Pathol</source>
          <year>2008</year>
          <volume>39</volume>
          <issue>8</issue>
          <fpage>1252</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="pmid">18547614</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-amjcaserep-16-509">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tewari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shukla</surname>
              <given-names>HS</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal stromal tumor</article-title>
          <source>Surg Oncol</source>
          <year>2008</year>
          <volume>17</volume>
          <fpage>129</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="pmid">18234489</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-amjcaserep-16-509">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miettinen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Monihan</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Sarlomo-Rikala</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>1999</year>
          <volume>23</volume>
          <issue>9</issue>
          <fpage>1109</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">10478672</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-amjcaserep-16-509">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nilsson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>B&#xFC;mming</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Meis-Kindblom</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era, a population-based study in western Sweden</article-title>
          <source>Cancer</source>
          <year>2005</year>
          <volume>103</volume>
          <issue>4</issue>
          <fpage>821</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">15648083</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-amjcaserep-16-509">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ji</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>ZW</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>LJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinicopathological characteristics of gastrointestinal mesenchymal tumors and diagnostic value of endoscopic ultrasonography</article-title>
          <source>J Gastroenterol Hepatol</source>
          <year>2008</year>
          <issue>8 Pt 2</issue>
          <fpage>318</fpage>
          <lpage>24</lpage>
        </element-citation>
      </ref>
      <ref id="b11-amjcaserep-16-509">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Berman</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Corless</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnosis of gastrointestinal stromal tumors: A consensus approach</article-title>
          <source>Hum Pathol</source>
          <year>2002</year>
          <volume>33</volume>
          <fpage>459</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">12094370</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-amjcaserep-16-509">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ueda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hijioka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A synchronous pancreatic neuroendocrine tumor and duodenal gastrointestinal stromal tumor</article-title>
          <source>Intern Med</source>
          <year>2014</year>
          <volume>53</volume>
          <issue>21</issue>
          <fpage>2483</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">25366007</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-amjcaserep-16-509">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akbulut</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yavuz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Otan</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hatipoglu</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Pancreatic extragastrointestinal stromal tumor: A case report and comprehensive literature review</article-title>
          <source>World J Gastrointest Surg</source>
          <year>2014</year>
          <volume>6</volume>
          <issue>9</issue>
          <fpage>175</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">25276287</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-amjcaserep-16-509">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>GS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Management and outcome of gastrointestinal stromal tumors of the duodenum</article-title>
          <source>J Gastrointest Surg</source>
          <year>2010</year>
          <volume>14</volume>
          <issue>5</issue>
          <fpage>880</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">20140534</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-amjcaserep-16-509">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoeppner</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kulemann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Marjanovic</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Limited resection for duodenal gastrointestinal stromal tumors: Surgical management and clinical outcome</article-title>
          <source>World J Gastrointest Surg</source>
          <year>2013</year>
          <volume>5</volume>
          <issue>2</issue>
          <fpage>16</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">23515427</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-amjcaserep-16-509">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>&#x10C;e&#x10D;ka</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jon</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ferko</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term survival of a patient after resection of a gastrointestinal stromal tumor arising from the pancreas</article-title>
          <source>Hepatobiliary Pancreat Dis Int</source>
          <year>2011</year>
          <volume>10</volume>
          <issue>3</issue>
          <fpage>330</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">21669581</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-amjcaserep-16-509">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dematteo</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Ballman</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Antonescu</surname>
              <given-names>CR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial</article-title>
          <source>Lancet</source>
          <year>2009</year>
          <volume>373</volume>
          <fpage>1097</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">19303137</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-amjcaserep-16-509">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rutkowski</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Przyby&#x142;</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zdzienicki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors: recommendations for patient selection, risk assessment, and molecular response monitoring</article-title>
          <source>Mol Diagn Ther</source>
          <year>2013</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">23355099</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-amjcaserep-16-509">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gold</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>van der Zwan</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>G&#xF6;nen</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Outcome of metastatic GIST in the era before tyrosine kinase inhibitors</article-title>
          <source>Ann Surg Oncol</source>
          <year>2007</year>
          <volume>14</volume>
          <fpage>134</fpage>
          <lpage>42</lpage>
          <comment>Erratum in: Ann Surg Oncol, 2007; 14: 3027</comment>
          <pub-id pub-id-type="pmid">17080234</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-amjcaserep-16-509">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vij</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Agrawal</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pandey</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Malignant extra-gastrointestinal stromal tumor of the pancreas. A case report and review of literature</article-title>
          <source>JOP</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>200</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">21386653</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-amjcaserep-16-509">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Debiec-Rychter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cools</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dumez</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistantmutants</article-title>
          <source>Gastroenterology</source>
          <year>2005</year>
          <volume>128</volume>
          <issue>2</issue>
          <fpage>270</fpage>
          <lpage>79</lpage>
          <pub-id pub-id-type="pmid">15685537</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-amjcaserep-16-509">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Trent</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>EF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors</article-title>
          <source>Cancer Res</source>
          <year>2004</year>
          <volume>64</volume>
          <issue>17</issue>
          <fpage>5913</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="pmid">15342366</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-amjcaserep-16-509" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Pancreatic GIST with ultrasonography.</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-509-g001"/>
    </fig>
    <fig id="f2-amjcaserep-16-509" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>Pancreatic GIST in computed tomography in relation with duodenum and vasculars (arrow).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-509-g002"/>
    </fig>
    <fig id="f3-amjcaserep-16-509" position="float">
      <label>Figure 3.</label>
      <caption>
        <p>Whipple procedure specimen and pancreatic GIST (arrow).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-509-g003"/>
    </fig>
    <fig id="f4-amjcaserep-16-509" position="float">
      <label>Figure 4.</label>
      <caption>
        <p>Immunohistochemistry CD34 positivity (&#xD7;200) (H&amp;E).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-509-g004"/>
    </fig>
    <fig id="f5-amjcaserep-16-509" position="float">
      <label>Figure 5.</label>
      <caption>
        <p>Immunohistochemistry CD117 positivity (&#xD7;200) (H&amp;E).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-509-g005"/>
    </fig>
    <fig id="f6-amjcaserep-16-509" position="float">
      <label>Figure 6.</label>
      <caption>
        <p>Relation between duodenum and tumor(&#xD7;40) (H&amp;E).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-509-g006"/>
    </fig>
    <fig id="f7-amjcaserep-16-509" position="float">
      <label>Figure 7.</label>
      <caption>
        <p>Relation between pancreas and tumor(&#xD7;40) (H&amp;E).</p>
      </caption>
      <graphic xlink:href="amjcaserep-16-509-g007"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
